ROPEGINTERFERON ALFA-2B

FDA Drug Profile — BESREMi, BESREMi Pen

ROPEGINTERFERON ALFA-2B is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including BESREMi, BESREMi Pen. Available dosage forms: injection, injection, solution.

Drug details

Generic Name
ROPEGINTERFERON ALFA-2B
Brand Names
BESREMi, BESREMi Pen
Application Number
BLA761166
Sponsor
PharmaEssentia USA
NDC Codes
5
Dosage Forms
INJECTION, INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
ROPEGINTERFERON ALFA-2B

Indications and Usage

1 INDICATIONS AND USAGE BESREMi is an interferon alfa-2b indicated for: • The treatment of adults with essential thrombocythemia. ( 1.1 ) • The treatment of adults with polycythemia vera. ( 1.2 ) 1.1 Essential Thrombocythemia BESREMi is indicated for the treatment of adults with essential thrombocythemia. 1.2 Polycythemia Vera BESREMi is indicated for the treatment of adults with polycythemia vera.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.